Compound News and Research

RSS

Gallstone formation may be driven by neutrophils

Neutrophils generate sticky webs of DNA called neutrophil extracellular traps (NETs) that act as a “glue” during gallstone formation.

19 Aug 2019

Chemists develop new approach based on graphene nanoflakes for drug delivery

Chemists funded by the SNSF have created a new compound for flexible drug delivery that specifically targets prostate cancer cells. Incorporating four different molecules, the compound prevents tumor cells from multiplying, can be detected by medical imaging and has staying power in the bloodstream.

19 Aug 2019

Fruit fly model for studying diseases like gout, kidney stones reveals new drug targets

A new fruit fly model that mimics diseases associated with high uric acid levels, such as gout and kidney stones, has revealed new targets for developing treatments for these diseases.

From PLOS ONE 16 Aug 2019

Ziath launches new YouTube channel to share its expertise with laboratories

Ziath is launching a new YouTube channel that will house informative videos previewing the latest innovations in the field of drug discovery and bio-banking sample management for the first time as the company seeks to share its expertise and knowledge with laboratories worldwide.

From Ziath Ltd 16 Aug 2019

Bile pigment may play an unexpected role in protecting the brain

In studies in mice, Johns Hopkins Medicine researchers report they have found that bilirubin, a bile pigment most commonly known for yellowing the skin of people with jaundice, may play an unexpected role in protecting brain cells from damage from oxidative stress.

From Johns Hopkins Medicine 13 Aug 2019

Newborn mouse model yields clues to cause of devastating gut disease in anemic preemies

Physicians have long suspected that red blood cell transfusions given to premature infants with anemia may put them in danger of developing necrotizing enterocolitis, or NEC, a potentially lethal inflammatory disease of the intestines.

From Johns Hopkins Medicine 13 Aug 2019

Porvair Sciences introduces 5 new deep well microplates

Porvair Sciences has extended its sample storage and collection range with the introduction of 5 new deep well microplates.

From Porvair Sciences Limited 13 Aug 2019

New T cell detection method promises personalized immunotherapy for melanomas

An important new study shows that better T cell detection is now possible using revolutionary technology. T cells are a type of lymphocyte, which in turn belongs to the diverse family of immune cells. They take part in cancer fighting as well as in most other immune responses.

12 Aug 2019

Bioinspired method detects and detoxifies harmful chemicals in single step

Many industrial and agriculture processes use chemicals that can be harmful for workers and the ecosystems where they accumulate.

12 Aug 2019

Decoding abnormal touch sensitivity in autism spectrum disorders

The inability to tolerate light touch is a telltale feature of autism and one of the disorder's many perplexing symptoms. It has defied treatment, and its precise origins have remained somewhat of a mystery.

12 Aug 2019

Longer-lived, but less toxic drug may work better for pancreatic cancer

Unlike many other cancers, most pancreatic tumors are rock hard.

9 Aug 2019

New way to identify inflammation occurring in eosinophil-related disorders

Diagnosing and monitoring an inflammatory gastrointestinal disease may soon become less invasive and more accurate, thanks to the pioneering research and commitment to patient health of three University of Utah physicians.

8 Aug 2019

Researchers discover promising approach to silence HIV infection

Researchers from The University of Texas Medical Branch at Galveston have discovered a new potential medication that works with an HIV-infected person's own body to further suppress the ever present but silent virus that available HIV treatments are unable to combat.

6 Aug 2019

Sanofi exercises option to advance innovative Bispecific Small Molecule project

Exscientia, the world-leading Artificial Intelligence (AI)-driven drug discovery company, today announced that Sanofi has exercised its option to progress an innovative Bispecific Small molecule project it discovered as part of its new modality collaboration.

From Sanofi 6 Aug 2019